Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-03 @ 11:46 PM
Study NCT ID:
NCT00077259
Status:
COMPLETED
Last Update Posted:
2013-01-16
First Post:
2004-02-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colorectal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent colon cancer | View |
| None | recurrent rectal cancer | View |
| None | stage III colon cancer | View |
| None | stage III rectal cancer | View |
| None | stage IV colon cancer | View |
| None | stage IV rectal cancer | View |
| None | adenocarcinoma of the colon | View |
| None | adenocarcinoma of the rectum | View |